Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wheeler, M. T.
Right arrow Articles by McNally, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheeler, M. T.
Right arrow Articles by McNally, E. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 18 2147-2154
© 2002 Oxford University Press

{zeta}-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy

Matthew T. Wheeler1, Sara Zarnegar2 and Elizabeth M. McNally2,3,*

1Department of Molecular Genetics and Cell Biology, 2Department of Medicine, Section of Cardiology and 3Department of Human Genetics, University of Chicago, Chicago, IL 60637, USA

Received May 3, 2002; Revised June 26, 2002; Accepted June 28, 2002

The dystrophin glycoprotein complex (DGC) is found at the plasma membrane of muscle cells, where it provides a link between the cytoskeleton and the extracellular matrix. A subcomplex within the DGC, the sarcoglycan complex, associates with dystrophin and mediates muscle membrane stability. Mutations in sarcoglycan genes lead to muscular dystrophy and cardiomyopathy in both humans and mice. In invertebrates, there are three sarcoglycan genes, while in mammals there are additional sarcoglycan genes that probably arose from gene duplication events. We identified a novel mammalian sarcoglycan, {zeta}-sarcoglycan, that is highly related to {gamma}-sarcoglycan and {delta}-sarcoglycan. We generated a {zeta}-sarcoglycan-specific antibody and found that {zeta}-sarcoglycan associated with other members of the sarcoglycan complex at the plasma membrane. Additionally, {zeta}-sarcoglycan was reduced at the membrane in muscular dystrophy, consistent with a role in mediating membrane stability. {zeta}-Sarcoglycan was also found as a component of the vascular smooth muscle sarcoglycan complex. Together, these data demonstrate that {zeta}-sarcoglycan is an integral component of the sarcoglycan complex and, as such, is important in the pathogenesis of muscular dystrophy.

* To whom correspondence should be addressed at: University of Chicago, Section of Cardiology, 5841 S. Maryland, MC 6088, Chicago, IL 60637, USA. Tel: +1 7737022672; Fax: +1 7737022681; Email: emcnally{at}medicine.bsd.uchicago.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Histochem. Cytochem.Home page
G. Anastasi, G. Cutroneo, A. Sidoti, C. Rinaldi, D. Bruschetta, G. Rizzo, R. D'Angelo, G. Tarone, A. Amato, and A. Favaloro
Sarcoglycan Subcomplex Expression in Normal Human Smooth Muscle
J. Histochem. Cytochem., August 1, 2007; 55(8): 831 - 843.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. T. Esapa, A. Waite, M. Locke, M. A. Benson, M. Kraus, R.A. J. McIlhinney, R. V. Sillitoe, P. W. Beesley, and D. J. Blake
SGCE missense mutations that cause myoclonus-dystonia syndrome impair {varepsilon}-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA
Hum. Mol. Genet., February 1, 2007; 16(3): 327 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. T. Wheeler, C. E. Korcarz, K. A. Collins, K. A. Lapidos, A. A. Hack, M. R. Lyons, S. Zarnegar, J. U. Earley, R. M. Lang, and E. M. McNally
Secondary Coronary Artery Vasospasm Promotes Cardiomyopathy Progression
Am. J. Pathol., March 1, 2004; 164(3): 1063 - 1071.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
M.T. WHEELER, M.J. ALLIKIAN, A. HEYDEMANN, and E.M. MCNALLY
The Sarcoglycan Complex in Striated and Vascular Smooth Muscle
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 389 - 398.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.